Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 17.2M | 9.8M | 12.6M | 11.7M | 13.0M |
| Operating Revenue | 17.1M | 9.8M | 12.5M | 11.7M | 13.0M |
| Cost Of Revenue | 3.7M | 2.9M | 3.0M | 2.2M | 3.4M |
| Gross Profit | 13.6M | 6.9M | 9.6M | 9.5M | 9.7M |
| Selling General And Administration | 6.3M | 3.6M | 3.7M | 3.7M | 4.8M |
| General And Administrative Expense | 6.3M | 3.6M | 3.7M | 3.7M | 4.8M |
| Other Operating Expenses | 29,000 | 211,000 | 41,000 | 42,000 | 19,000 |
| Operating Expense | 6.3M | 3.8M | 3.7M | 3.7M | 4.8M |
| Operating Income | 7.2M | 3.1M | 5.9M | 5.8M | 4.9M |
| EBIT | 351.9M | 4.2M | 5.4M | 89.0M | 5.7M |
| Interest Expense | 1.5M | 2.0M | 2.0M | 2.3M | 2.5M |
| Interest Expense Non Operating | 1.5M | 2.0M | 2.0M | 2.3M | 2.5M |
| Net Interest Income | -1.5M | -2.0M | -2.0M | -2.3M | -2.5M |
| Other Income Expense | 344.7M | 1.1M | -531,000 | 83.2M | 843,000 |
| Special Income Charges | 339.6M | -12,000 | 19,000 | 85.6M | -65,000 |
| Gain On Sale Of Security | 4.6M | 2.6M | -538,000 | -2.4M | 502,000 |
| Earnings From Equity Interest | 535,000 | -1.5M | -12,000 | -70,000 | 406,000 |
| Pretax Income | 350.5M | 2.1M | 3.3M | 86.6M | 3.2M |
| Tax Provision | 85.5M | -3.4M | -3.0M | 1.2M | -12,000 |
| Tax Effect Of Unusual Items | 84.0M | 381,600 | -77,850 | 1.1M | 65,550 |
| Net Income From Continuing And Discontinued Operation | 264.7M | 5.3M | 6.2M | 84.8M | 2.9M |
| Net Income From Continuing Operation Net Minority Interest | 264.7M | 5.3M | 6.2M | 84.8M | 2.9M |
| Net Income Including Noncontrolling Interests | 264.9M | 5.5M | 6.3M | 85.5M | 3.2M |
| Minority Interests | -222,000 | -169,000 | -143,000 | -712,000 | -359,000 |
| Net Income Common Stockholders | 264.7M | 5.3M | 6.2M | 84.8M | 2.9M |
| Net Income | 264.7M | 5.3M | 6.2M | 84.8M | 2.9M |
| EBITDA | 353.5M | 5.5M | 6.5M | 90.3M | 7.5M |
| Normalized EBITDA | 9.3M | 3.0M | 7.0M | 7.0M | 7.1M |
| Reconciled Depreciation | 1.6M | 1.3M | 1.1M | 1.3M | 1.8M |
| Basic EPS | 5.72 | 0.12 | 0.13 | -- | 0.06 |
| Diluted EPS | 5.63 | 0.11 | 0.13 | -- | 0.06 |
| Basic Average Shares | 46.3M | 46.3M | 46.3M | -- | 46.5M |
| Diluted Average Shares | 47.1M | 47.3M | 47.4M | -- | 47.5M |
| Total Unusual Items | 344.2M | 2.5M | -519,000 | 83.3M | 437,000 |
| Total Unusual Items Excluding Goodwill | 344.2M | 2.5M | -519,000 | 83.3M | 437,000 |
| Tax Rate For Calcs | 0.24 | 0.15 | 0.15 | 0.01 | 0.15 |
| Normalized Income | 4.5M | 3.2M | 6.6M | 2.6M | 2.5M |
| Diluted NI Availto Com Stockholders | 264.7M | 5.3M | 6.2M | 84.8M | 2.9M |
| Gain On Sale Of Ppe | 339.6M | -12,000 | 19,000 | 25,000 | -65,000 |
| Net Income Continuous Operations | 264.9M | 5.5M | 6.3M | 85.5M | 3.2M |
| Net Non Operating Interest Income Expense | -1.5M | -2.0M | -2.0M | -2.3M | -2.5M |
| Other Gand A | 1.3M | 953,000 | 841,000 | 847,000 | 1.5M |
| Reconciled Cost Of Revenue | 3.7M | 2.9M | 3.0M | 2.2M | 3.4M |
| Salaries And Wages | 5.0M | 2.7M | 2.8M | 2.8M | 3.3M |
| Total Expenses | 10.0M | 6.7M | 6.7M | 5.9M | 8.2M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 353.0M | 11.1M | 12.1M | 15.9M | 109.6M |
| Cash Cash Equivalents And Short Term Investments | 353.0M | 11.1M | 12.1M | 15.9M | 109.6M |
| Accounts Receivable | 6.0M | 4.7M | 5.5M | 7.4M | 9.2M |
| Receivables | 13.3M | 12.3M | 13.4M | 8.1M | 17.4M |
| Current Assets | 366.3M | 23.5M | 25.5M | 24.0M | 127.0M |
| Gross PPE | 8.4M | 8.6M | 9.3M | 9.4M | 9.1M |
| Accumulated Depreciation | -65.1M | -63.6M | -62.3M | -61.3M | -60.0M |
| Net PPE | 8.4M | 8.6M | 9.3M | 9.4M | 9.1M |
| Goodwill And Other Intangible Assets | 196.1M | 197.6M | 198.8M | 199.9M | 202.6M |
| Other Intangible Assets | 196.1M | 197.6M | 198.8M | 199.9M | 202.6M |
| Investments And Advances | 412.5M | 449.3M | 473.1M | 464.4M | 441.2M |
| Long Term Equity Investment | 223.7M | 216.8M | 230.7M | 230.8M | 213.1M |
| Other Investments | 188.8M | 232.5M | -- | -- | 228.1M |
| Total Non Current Assets | 648.7M | 693.2M | 693.6M | 689.9M | 664.6M |
| Total Assets | 1.0B | 716.7M | 719.1M | 714.0M | 791.6M |
| Current Debt And Capital Lease Obligation | 8.0M | 8.0M | 8.0M | 8.0M | 8.0M |
| Accounts Payable | 8.1M | 1.8M | 610,000 | 3.3M | 6.0M |
| Payables | 35.3M | 2.0M | 772,000 | 4.8M | 7.2M |
| Payables And Accrued Expenses | 35.3M | 2.0M | 772,000 | 4.8M | 7.2M |
| Current Liabilities | 43.3M | 10.0M | 8.8M | 12.8M | 15.2M |
| Long Term Debt | 83.2M | 93.2M | 97.3M | 99.4M | 98.1M |
| Long Term Debt And Capital Lease Obligation | 83.2M | 93.2M | 97.3M | 99.4M | 98.1M |
| Other Non Current Liabilities | 308,000 | 332,000 | 370,000 | 409,000 | 405,000 |
| Total Non Current Liabilities Net Minority Interest | 112.1M | 126.2M | 129.0M | 130.1M | 146.5M |
| Total Liabilities Net Minority Interest | 155.4M | 136.1M | 137.7M | 142.9M | 161.7M |
| Common Stock | 353.4M | 353.4M | 353.3M | 353.0M | 354.0M |
| Capital Stock | 353.4M | 353.4M | 353.3M | 353.0M | 354.0M |
| Retained Earnings | 334.2M | 85.0M | 83.8M | 81.8M | 9.2M |
| Gains Losses Not Affecting Retained Earnings | 162.0M | 132.3M | 134.3M | 126.3M | 140.3M |
| Other Equity Adjustments | 162.0M | 132.3M | 134.3M | 126.3M | 140.3M |
| Common Stock Equity | 849.6M | 570.7M | 571.5M | 561.2M | 503.5M |
| Stockholders Equity | 849.6M | 570.7M | 571.5M | 561.2M | 503.5M |
| Total Equity Gross Minority Interest | 859.5M | 580.5M | 581.3M | 571.1M | 629.9M |
| Minority Interest | 9.9M | 9.8M | 9.9M | 10.0M | 126.4M |
| Total Capitalization | 932.8M | 663.9M | 668.8M | 660.6M | 601.7M |
| Net Tangible Assets | 653.6M | 373.2M | 372.6M | 361.3M | 301.0M |
| Tangible Book Value | 653.6M | 373.2M | 372.6M | 361.3M | 301.0M |
| Working Capital | 323.0M | 13.5M | 16.7M | 11.3M | 111.8M |
| Invested Capital | 932.8M | 663.9M | 668.8M | 660.6M | 601.7M |
| Total Debt | 91.2M | 101.2M | 105.3M | 107.4M | 106.1M |
| Net Debt | -- | 82.0M | 85.2M | 83.5M | -- |
| Share Issued | 46.3M | 46.3M | 46.3M | 46.3M | 46.5M |
| Ordinary Shares Number | 46.3M | 46.3M | 46.3M | 46.3M | 46.5M |
| Available For Sale Securities | -- | -- | 242.4M | 233.6M | -- |
| Financial Assets | 20.5M | 21.0M | 158,000 | 312,000 | 607,000 |
| Income Tax Payable | 27.2M | 188,000 | 162,000 | 1.5M | 1.2M |
| Investmentin Financial Assets | -- | -- | 242.4M | 233.6M | -- |
| Investmentsin Associatesat Cost | -- | -- | -- | 0.00 | 0.00 |
| Investmentsin Joint Venturesat Cost | 223.7M | 216.8M | 230.7M | 230.8M | 213.1M |
| Loans Receivable | 7.0M | 6.9M | 7.2M | 0.00 | 6.8M |
| Non Current Deferred Assets | 11.2M | 16.8M | 12.2M | 8.8M | 11.1M |
| Non Current Deferred Liabilities | 28.6M | 32.7M | 31.3M | 30.3M | 47.9M |
| Non Current Deferred Taxes Assets | 11.2M | 16.8M | 12.2M | 8.8M | 11.1M |
| Non Current Deferred Taxes Liabilities | 28.6M | 32.7M | 31.3M | 30.3M | 47.9M |
| Non Current Note Receivables | 0.00 | 0.00 | 0.00 | 7.2M | 0.00 |
| Taxes Receivable | 297,000 | 743,000 | 763,000 | 749,000 | 1.4M |
| Total Tax Payable | 27.2M | 188,000 | 162,000 | 1.5M | 1.2M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | 15.1M | 4.4M | 3.8M | 3.1M | 10.7M |
| Cash Flow From Continuing Operating Activities | 15.1M | 4.4M | 3.8M | 3.1M | 10.7M |
| Depreciation Amortization Depletion | 1.6M | 1.3M | 1.1M | 1.3M | 1.8M |
| Stock Based Compensation | 1.3M | 1.1M | 1.2M | 1.2M | 936,000 |
| Deferred Tax | 85.5M | -3.4M | -3.0M | 1.2M | -12,000 |
| Deferred Income Tax | 85.5M | -3.4M | -3.0M | 1.2M | -12,000 |
| Change In Working Capital | 1.2M | 1.4M | -731,000 | -3.6M | 3.0M |
| Changes In Account Receivables | -1.4M | 823,000 | 1.9M | -917,000 | -127,000 |
| Change In Receivables | -1.4M | 823,000 | 1.9M | -917,000 | -127,000 |
| Change In Payables And Accrued Expense | 2.5M | 571,000 | -2.6M | -2.7M | 3.1M |
| Other Non Cash Items | 1.5M | 2.2M | 2.1M | 2.4M | 2.5M |
| Capital Expenditure | -1,000 | -7,000 | -3,000 | -459,000 | -1.4M |
| Purchase Of PPE | -1,000 | -7,000 | -3,000 | -319,000 | -291,000 |
| Net PPE Purchase And Sale | -111,000 | 649,000 | 33,000 | -319,000 | -291,000 |
| Purchase Of Business | 0.00 | 0.00 | 0.00 | -85.3M | -4.8M |
| Sale Of Business | 346,000 | 281,000 | 240,000 | 172,000 | 186,000 |
| Purchase Of Investment | -2.9M | -392,000 | 0.00 | -7.0M | -62,000 |
| Sale Of Investment | 67.6M | 292,000 | 527,000 | 4.1M | 6.6M |
| Net Investment Purchase And Sale | 64.7M | -100,000 | 527,000 | -2.9M | 6.5M |
| Investing Cash Flow | 353.3M | 619,000 | 759,000 | -88.4M | 580,000 |
| Cash Flow From Continuing Investing Activities | 353.3M | 619,000 | 759,000 | -88.4M | 580,000 |
| Repayment Of Debt | -11.0M | -2.0M | -2.0M | -2.0M | -2.0M |
| Net Issuance Payments Of Debt | -11.0M | -2.0M | -2.0M | -2.0M | -2.0M |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase Of Capital Stock | -1.5M | 0.00 | -52,000 | -5.5M | 0.00 |
| Net Common Stock Issuance | -1.5M | 0.00 | -52,000 | -5.5M | 0.00 |
| Common Stock Dividend Paid | -4.2M | -3.8M | -3.8M | -3.6M | -3.9M |
| Common Stock Payments | -1.5M | 0.00 | -52,000 | -5.5M | 0.00 |
| Financing Cash Flow | -26.5M | -6.0M | -8.4M | -11.2M | -10.0M |
| Cash Flow From Continuing Financing Activities | -26.5M | -6.0M | -8.4M | -11.2M | -10.0M |
| Effect Of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 2.9M | -1.1M |
| Changes In Cash | 341.9M | -961,000 | -3.8M | -96.6M | 1.3M |
| Beginning Cash Position | 11.1M | 12.1M | 15.9M | 109.6M | 109.4M |
| End Cash Position | 353.0M | 11.1M | 12.1M | 15.9M | 109.6M |
| Free Cash Flow | 15.1M | 4.4M | 3.8M | 2.6M | 9.4M |
| Asset Impairment Charge | 0.00 | -- | -- | -42,000 | 65,000 |
| Cash Dividends Paid | -4.2M | -3.8M | -3.8M | -3.6M | -3.9M |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Losses From Equity Investments | -535,000 | 1.5M | 12,000 | 1.6M | -406,000 |
| Gain Loss On Investment Securities | 412,000 | -802,000 | 715,000 | -159,000 | 8,000 |
| Gain Loss On Sale Of PPE | -339.6M | 0.00 | -19,000 | -25,000 | 0.00 |
| Interest Paid Cfo | -1.8M | -1.8M | -1.9M | -2.1M | -2.2M |
| Long Term Debt Payments | -11.0M | -2.0M | -2.0M | -2.0M | -2.0M |
| Net Business Purchase And Sale | 346,000 | 281,000 | 240,000 | -85.1M | -4.6M |
| Net Foreign Currency Exchange Gain Loss | 860,000 | -2.3M | -230,000 | 3.1M | -590,000 |
| Net Income From Continuing Operations | 264.9M | 5.5M | 6.3M | 85.5M | 3.2M |
| Net Intangibles Purchase And Sale | -- | -- | -- | -140,000 | -- |
| Net Long Term Debt Issuance | -11.0M | -2.0M | -2.0M | -2.0M | -2.0M |
| Net Other Financing Charges | -177,000 | -201,000 | -233,000 | -171,000 | -1.7M |
| Net Other Investing Changes | -29,000 | -211,000 | -41,000 | -42,000 | -19,000 |
| Operating Gains Losses | -338.9M | -1.6M | 478,000 | -82.6M | -988,000 |
| Proceeds From Stock Option Exercised | -9.6M | 0.00 | -2.3M | 0.00 | -2.4M |
| Purchase Of Intangibles | -- | -- | -- | -140,000 | -- |
| Sale Of PPE | -110,000 | 656,000 | 36,000 | 0.00 | 0.00 |
| Taxes Refund Paid | -227,000 | -340,000 | -1.8M | -156,000 | 2.4M |